SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
NDC 52536-175, sodium sulfate, potassium sulfate, magnesium sulfate, solution, concentrate, from Wilshire Pharmaceuticals, Inc..
- Product NDC
- 52536-175
- Status
- Listed
- Labeler
- Wilshire Pharmaceuticals, Inc.
- Dosage form
- SOLUTION, CONCENTRATE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022372
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52536-175 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM SULFATE17.5 g/mL
- POTASSIUM SULFATE3.13 g/mL
- MAGNESIUM SULFATE, UNSPECIFIED FORM1.6 g/mL
Pharmacologic classes
Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52536-175-01 | 52536017501 | 2 BOTTLE, PLASTIC in 1 CARTON (52536-175-01) / 177.4 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f269929e-c2ff-4288-9d3b-7770bcb5a498NADAC price for package 52536017501
GET /v1/drugs/nadac/52536017501
Use it
Look up 52536-175 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52536-175 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52536-175. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.